OM
TECX

Opaleye Management’s Tectonic Therapeutic TECX Stock Holding History

Opaleye Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-123,000
Closed -$3.8M – 66
2026
Q1 		$3.8M Sell
123,000
-91,747
-43% -$2.26M 0.5% 36
2025
Q4 		$4.48M Buy
+214,747
New +$3.99M 0.59% 33

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Opaleye Management's TECX Position: Q2 2026 in Review

Opaleye Management sold out of Tectonic Therapeutic (TECX) in Q2 2026, closing a stake of 123,000 shares — an estimated $3.8M sold.

Opaleye Management first reported a position in TECX in Q4 2025 and held it in 2 quarters. The position peaked at $4.48M in Q4 2025. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Opaleye Management reported no remaining Tectonic Therapeutic position as of Q2 2026 after selling out during the quarter.
  • Opaleye Management sold 123,000 Tectonic Therapeutic shares in Q2 2026, an estimated $3.8M.
  • Opaleye Management first reported a position in Tectonic Therapeutic in Q4 2025 and held it in 2 quarters.
  • Opaleye Management's Tectonic Therapeutic position peaked at $4.48M in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Opaleye Management's 13F filing for Q2 2026, filed 14 Aug 2026.